Triple-negative breast cancer (TNBC) is a distinct and aggressive subtype of breast cancer characterized by the absence of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) expression (1). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.